Cardiology
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genetics
Geriatrics/Aging
Hematology/Oncology
Immunology/Allergy
Infectious Disease
Nephrology
Neurology/Neurosurgery
Obstetrics/Gynecology
Pediatrics
Psychiatry
Public Health, Policy, and Training
Pulmonary
Rheumatology
Surgery

Nejm News Une Mise à Jour The New England Journal of Medicine by Specialties

 


The New England Journal of Medicine: Search Results in Hematology\Oncology
The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Hematology\Oncology. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.

Screening for Colorectal Neoplasia
01/01/70 - Foreword. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author?s clinical recommendations. Stage. A 79-year-old…

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
01/01/70 - Neuroendocrine tumors of the midgut (which is defined as the jejunoileum and the proximal colon) commonly metastasize to the mesentery, peritoneum, and liver and are frequently associated with the carcinoid syndrome. Neuroendocrine tumors of the midgut represent the most common type of malignant…

Rethinking the Ban ? The U.S. Blood Supply and Men Who Have Sex with Men
01/01/70 - After the magnitude of the June 12, 2016, massacre at the Pulse nightclub became clear, people throughout Orlando wanted to help in any way they could. Thousands volunteered to give blood; local restaurants offered free food and water to those waiting in hours-long blood-bank lines in the central…

The 21st Century Cures Act ? A View from the NIH
01/01/70 - The Cures Act, formally known as H.R. 34 or the 21st Century Cures Act, passed overwhelmingly in the U.S. House of Representatives and Senate in the waning days of the 114th Congress and was signed into law by President Barack Obama on December 13, 2016. Weighing in at nearly 1000 pages, this…

TARGT Gene Therapy Platform for Correction of Anemia in End-Stage Renal Disease
01/01/70 - To the Editor: Anemia in patients with end-stage renal disease who are undergoing hemodialysis is caused, in part, by a reduction in or absence of secretion of endogenous erythropoietin. Recombinant human erythropoietin given intravenously has been associated with an increased risk of…

Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab
01/01/70 - To the Editor: Inhibition of immune checkpoints with the use of antibodies targeting programmed cell death 1 (PD-1) or monoclonal antibodies against cytotoxic T-lymphocyte?associated antigen 4 (CTLA-4) has been used clinically in patients with various types of cancer. In the limited number of…

After the Party?s Over
01/01/70 - Foreword. In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors? commentary follows. Stage. While driving home from an evening…

Implantation of an Artificial Larynx after Total Laryngectomy
01/01/70 - To the Editor: Organ loss due to late-stage cancer is a heavy burden on both the patient and the health care system. Total laryngectomy in patients with advanced laryngeal or hypopharyngeal carcinoma is lifesaving, but it entails a substantial loss of quality of life because of altered…

Gastric Cancer in Chest Radiograph
01/01/70 - Figure 1.

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
01/01/70 - Glioblastoma, an aggressive primary brain tumor, is among the most lethal of human cancers. We present evidence of the potential therapeutic benefit of adoptive T-cell therapy against glioblastoma with the use of CAR-engineered T cells targeting IL13R?2, a glioma-associated antigen linked to a…

Copyright © 2004/2011 Health.Cat

Annuaire de Sante | S'inscrire au MedSante  | Dictionnaire medicale  Forumed des médecins